Clinical Trials Arena July 26, 2024
GlobalData

Medidata’s Clinical Data Studio will be used to streamline trials and improve patient experience.

Eisai has adopted Medidata’s Clinical Data Studio, which aims to transform and modernising the clinical trial efficiency and patient experience.

Launched last month, this AI-driven platform is expected to grant Eisai control over its clinical data, facilitate the execution of scalable and complex trials, and enhance the overall patient experience.

The Clinical Data Studio is a component of the Medidata platform, which centrally manages data from various sources. This integration could be crucial for improving data reliability across the entire trial ecosystem, the company noted.

Medidata global head of sales and executive vice-president Janet Butler said: “Through Clinical Data Studio, Eisai is enabling healthcare stakeholders to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Clinical Trials, Technology, Trends
AI tool helps find life-saving medicine for rare disease
Report: AI controls growing VC attention in Europe
Affineon Health Raises $5M for AI-Powered Physician Inbox Management
Will biased AI ruin everything?
Sam Altman’s Fusion Power Startup Is Eyeing Trump’s $500 Billion AI Play

Share This Article